268 related articles for article (PubMed ID: 29301038)
1. Gaucher disease iPSC-derived osteoblasts have developmental and lysosomal defects that impair bone matrix deposition.
Panicker LM; Srikanth MP; Castro-Gomes T; Miller D; Andrews NW; Feldman RA
Hum Mol Genet; 2018 Mar; 27(5):811-822. PubMed ID: 29301038
[TBL] [Abstract][Full Text] [Related]
2. Altered Differentiation Potential of Gaucher's Disease iPSC Neuronal Progenitors due to Wnt/β-Catenin Downregulation.
Awad O; Panicker LM; Deranieh RM; Srikanth MP; Brown RA; Voit A; Peesay T; Park TS; Zambidis ET; Feldman RA
Stem Cell Reports; 2017 Dec; 9(6):1853-1867. PubMed ID: 29198828
[TBL] [Abstract][Full Text] [Related]
3. Elevated Dkk1 Mediates Downregulation of the Canonical Wnt Pathway and Lysosomal Loss in an iPSC Model of Neuronopathic Gaucher Disease.
Srikanth MP; Feldman RA
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287247
[TBL] [Abstract][Full Text] [Related]
4. Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cells.
Awad O; Sarkar C; Panicker LM; Miller D; Zeng X; Sgambato JA; Lipinski MM; Feldman RA
Hum Mol Genet; 2015 Oct; 24(20):5775-88. PubMed ID: 26220978
[TBL] [Abstract][Full Text] [Related]
5. Novel beta-glucocerebrosidase chaperone compounds identified from cell-based screening reduce pathologically accumulated glucosylsphingosine in iPS-derived neuronal cells.
Naito Y; Sakamoto S; Kojima T; Homma M; Tanaka M; Matsui H
SLAS Discov; 2023 Oct; 28(7):344-349. PubMed ID: 37369311
[TBL] [Abstract][Full Text] [Related]
6. Assessment of cellular cobalamin metabolism in Gaucher disease.
Basgalupp SP; Siebert M; Ferreira C; Behringer S; Spiekerkoetter U; Hannibal L; Schwartz IVD
BMC Med Genet; 2020 Jan; 21(1):12. PubMed ID: 31931749
[TBL] [Abstract][Full Text] [Related]
7. Glucocerebrosidase deficiency in zebrafish affects primary bone ossification through increased oxidative stress and reduced Wnt/β-catenin signaling.
Zancan I; Bellesso S; Costa R; Salvalaio M; Stroppiano M; Hammond C; Argenton F; Filocamo M; Moro E
Hum Mol Genet; 2015 Mar; 24(5):1280-94. PubMed ID: 25326392
[TBL] [Abstract][Full Text] [Related]
8. Impact of sphingolipids on osteoblast and osteoclast activity in Gaucher disease.
Reed MC; Schiffer C; Heales S; Mehta AB; Hughes DA
Mol Genet Metab; 2018 Aug; 124(4):278-286. PubMed ID: 29934064
[TBL] [Abstract][Full Text] [Related]
9. mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cells.
Brown RA; Voit A; Srikanth MP; Thayer JA; Kingsbury TJ; Jacobson MA; Lipinski MM; Feldman RA; Awad O
Dis Model Mech; 2019 Oct; 12(10):. PubMed ID: 31519738
[TBL] [Abstract][Full Text] [Related]
10. C5a Activates a Pro-Inflammatory Gene Expression Profile in Human Gaucher iPSC-Derived Macrophages.
Serfecz JC; Saadin A; Santiago CP; Zhang Y; Bentzen SM; Vogel SN; Feldman RA
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576075
[TBL] [Abstract][Full Text] [Related]
11. Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development.
Panicker LM; Miller D; Awad O; Bose V; Lun Y; Park TS; Zambidis ET; Sgambato JA; Feldman RA
Stem Cells; 2014 Sep; 32(9):2338-49. PubMed ID: 24801745
[TBL] [Abstract][Full Text] [Related]
12. Potential Binding Sites of Pharmacological Chaperone NCGC00241607 on Mutant β-Glucocerebrosidase and Its Efficacy on Patient-Derived Cell Cultures in Gaucher and Parkinson's Disease.
Kopytova AE; Rychkov GN; Cheblokov AA; Grigor'eva EV; Nikolaev MA; Yarkova ES; Sorogina DA; Ibatullin FM; Baydakova GV; Izyumchenko AD; Bogdanova DA; Boitsov VM; Rybakov AV; Miliukhina IV; Bezrukikh VA; Salogub GN; Zakharova EY; Pchelina SN; Emelyanov AK
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240451
[TBL] [Abstract][Full Text] [Related]
13. Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis.
Sgambato JA; Park TS; Miller D; Panicker LM; Sidransky E; Lun Y; Awad O; Bentzen SM; Zambidis ET; Feldman RA
Stem Cells Transl Med; 2015 Aug; 4(8):878-86. PubMed ID: 26062980
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cell line (INSAi001-A) from a Gaucher disease type 3 patient compound heterozygote for mutations in the GBA1 gene.
Duarte AJ; Ribeiro D; Santos R; Moreira L; Bragança J; Amaral O
Stem Cell Res; 2019 Dec; 41():101595. PubMed ID: 31678773
[TBL] [Abstract][Full Text] [Related]
15. Increased NF-κB Activity and Decreased Wnt/β-Catenin Signaling Mediate Reduced Osteoblast Differentiation and Function in ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mice.
Le Henaff C; Mansouri R; Modrowski D; Zarka M; Geoffroy V; Marty C; Tarantino N; Laplantine E; Marie PJ
J Biol Chem; 2015 Jul; 290(29):18009-18017. PubMed ID: 26060255
[TBL] [Abstract][Full Text] [Related]
16. A Drosophila Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin.
Kinghorn KJ; Grönke S; Castillo-Quan JI; Woodling NS; Li L; Sirka E; Gegg M; Mills K; Hardy J; Bjedov I; Partridge L
J Neurosci; 2016 Nov; 36(46):11654-11670. PubMed ID: 27852774
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease.
Mucci JM; Suqueli García F; de Francesco PN; Ceci R; Di Genaro S; Fossati CA; Delpino MV; Rozenfeld PA
Gene; 2013 Dec; 532(2):186-91. PubMed ID: 24076352
[TBL] [Abstract][Full Text] [Related]
18. A transcriptional and post-transcriptional dysregulation of Dishevelled 1 and 2 underlies the Wnt signaling impairment in type I Gaucher disease experimental models.
Costa R; Bellesso S; Lualdi S; Manzoli R; Pistorio V; Filocamo M; Moro E
Hum Mol Genet; 2020 Jan; 29(2):274-285. PubMed ID: 31816052
[TBL] [Abstract][Full Text] [Related]
19. Elevated glucosylsphingosine in Gaucher disease induced pluripotent stem cell neurons deregulates lysosomal compartment through mammalian target of rapamycin complex 1.
Srikanth MP; Jones JW; Kane M; Awad O; Park TS; Zambidis ET; Feldman RA
Stem Cells Transl Med; 2021 Jul; 10(7):1081-1094. PubMed ID: 33656802
[TBL] [Abstract][Full Text] [Related]
20. Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathology.
Sun Y; Florer J; Mayhew CN; Jia Z; Zhao Z; Xu K; Ran H; Liou B; Zhang W; Setchell KD; Gu J; Grabowski GA
PLoS One; 2015; 10(3):e0118771. PubMed ID: 25822147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
